Clinical use of tumor markers in oncology
EL Jacobs, CM Haskell - Current problems in cancer, 1991 - Elsevier
The perfect tumor marker would be one that was produced solely by a tumor and secreted in
measurable amounts into body fluids, it should be present only in the presence of cancer, it …
measurable amounts into body fluids, it should be present only in the presence of cancer, it …
The use of serologic tumor markers in gastrointestinal malignancies
MR Posner, RJ Mayer - Hematology/oncology clinics of North America, 1994 - Elsevier
Clinicians have desired simple tests that could be applied to readily diagnose
gastrointestinal cancers at an early stage and to subsequently monitor the treatment of these …
gastrointestinal cancers at an early stage and to subsequently monitor the treatment of these …
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines
MJ Duffy, A van Dalen, C Haglund, L Hansson… - European journal of …, 2003 - Elsevier
In recent years, numerous serum and cell/tissue-based markers have been described for
colorectal cancer (CRC). The aim of this article was to provide guidelines for the routine …
colorectal cancer (CRC). The aim of this article was to provide guidelines for the routine …
[HTML][HTML] Carcinoembryonic antigen, carbohydrate antigen 19-9, cancer antigen 125, prostate-specific antigen and other cancer markers: a primer on commonly used …
S Desai, AK Guddati - World Journal of Oncology, 2023 - ncbi.nlm.nih.gov
Cancer markers are molecules produced by cancer cells which may serve to identify the
presence of cancer. Cancer markers can be differentiated as serum-based, radiology-based …
presence of cancer. Cancer markers can be differentiated as serum-based, radiology-based …
Role of tumor markers in patients with solid cancers: a critical review
MJ Duffy - European journal of internal medicine, 2007 - Elsevier
The measurement of tumor markers is currently one of the most rapidly growing areas in
laboratory medicine. Lack of sensitivity and specificity preclude the use of most existing …
laboratory medicine. Lack of sensitivity and specificity preclude the use of most existing …
[HTML][HTML] Serum tumor markers
GL Perkins, ED Slater, GK Sanders… - American family physician, 2003 - aafp.org
Monoclonal antibodies are used to detect serum antigens associated with specific
malignancies. These tumor markers are most useful for monitoring response to therapy and …
malignancies. These tumor markers are most useful for monitoring response to therapy and …
Validation of new cancer biomarkers: a position statement from the European group on tumor markers
BACKGROUND Biomarkers are playing increasingly important roles in the detection and
management of patients with cancer. Despite an enormous number of publications on …
management of patients with cancer. Despite an enormous number of publications on …
Tumor markers
JYH Chan, Z Wang - Lau WY. Hepatocelluar carcinoma …, 2008 - books.google.com
Chronic hepatitis leading to liver cirrhosis is a major risk factor for the development of
hepatocellular carcinoma (HCC). Patients with severe chronic hepatitis and cirrhosis should …
hepatocellular carcinoma (HCC). Patients with severe chronic hepatitis and cirrhosis should …
Estimating the probability of cancer with several tumor markers in patients with colorectal disease
M Carpelan-Holmström, J Louhimo, UH Stenman… - Oncology, 2004 - karger.com
Objective: The purpose of this study was to evaluate and compare serum tumor markers,
carcinoembryonic antigen (CEA), CA 19-9, CA 242, CA 72-4 and hCGβ, and their value in …
carcinoembryonic antigen (CEA), CA 19-9, CA 242, CA 72-4 and hCGβ, and their value in …